Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Gene mutation causes sight loss in dogs and humans
In healthy dogs, ABCA4 plays a vital role in the normal visual cycle when light hits the eye.
Study finds ABCA4 mutation causes retinal degenerative diseases 

Scientists have identified a genetic mutation that causes retinal degenerative diseases in both humans and dogs.

In children and young adults, Stargardt disease is one of the most common types of inherited retinal degenerative disease. Now, an international research team has found that a mutation in the ABCA4 gene causes a similar disease in Labrador retrievers.

Published in PLOS Genetics, the findings could help to breed healthy dogs and develop novel treatment for human patients.

Labradors can suffer from inherited conditions such as progressive retinal atrophy (PRA), which is caused by the degeneration of photoreceptor cells. In humans, this is called retinitis pigmentosa (RP).

Until now, only one mutation in the PRCD gene had been found to cause inherited retinal degeneration in Labradors. But 10 years ago a dog was found to have visual impairment not caused by the previously known mutation.

In healthy dogs, ABCA4 plays a vital role in the normal visual cycle when light hits the eye. According to the new findings, dogs affected by the mutation cannot produce a functional ABCA4 protein. Toxic byproducts produced when the photoreceptors detect light cause cell death and lead to visual impairment.

Mutations in the ABCA4 gene are the major case of Stargardt disease in humans, which affects around one in 8,000-10,000 children and young adults. Scientists say disease progression appears to be similar in Labradors.

Study director Tomas Bergström said: “We hope that the results of this study will not only support breeding of healthy dogs, but also enhance the development of new treatments for children and young adults with Stargardt disease.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.